Оцінювання якості життя та психоемоційного стану пацієнтів із цукровим діабетом та серцево-судинними захворюваннями в умовах війни

Type 2 diabetes mellitus and cardiovascular diseases (CVDs) are among the most common chronic diseases that significantly impair patients’ quality of life and increase the risk of serious complications. The objective. To assess the psychoemotional state, in particular the level of anxiety, depressive symptoms, stress, and quality of life in patients with type 2 diabetes mellitus and CVDs. Materials and methods. The study was conducted at the endocrinology and cardiology departments of the Ternopil Regional Hospital from 2021 to 2024. The study involved 78 male patients aged 30 to 60 with type II diabetes and/or CVD. The psychological and emotional state was assessed using the GAD-7 (anxiety level), BDI (depressive symptoms) scales and the Holmes and Rahe methods for determining stress resistance. The quality of life of patients was assessed using the SF-36 questionnaire. Results. The results showed a significant decrease in quality of life and stress resistance, as well as an increase in depression and anxiety levels in patients with a combination of type 2 diabetes and CVD compared to patients suffering from only one of these diseases. Patients with comorbidities experienced a significant increase in psychological and emotional stress, indicating the need for a comprehensive approach to treatment, including psychological and emotional support. The psychological and emotional state of patients has a significant impact on their quality of life and the effectiveness of therapy. Conclusions. Increased levels of stress, depression, and anxiety contribute to the deterioration of patients’ overall condition, reduce their ability to cope with chronic diseases, and complicate treatment. It is necessary to integrate psychotherapeutic strategies into the therapeutic process. Further research should focus on the implementation of effective psychotherapeutic techniques aimed at reducing the psychoemotional burden in patients with comorbidities.